Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Subst Abuse Treat. 2019 Sep 5;106:89–96. doi: 10.1016/j.jsat.2019.09.002

Table 6:

Treatment outcomes by change in employment status.

Contrast 1 UU vs UE Contrast 2 EU vs EE Contrast 3 EE vs UE Contrast 4 EU vs UE Contrast 5 UU vs EU Contrast 6 UU vs EE
B/SE OR/t p. B/SE. OR/t p. B/SE. OR/t p. B/SE. OR/t p. B/SE OR/t p. B/SE OR/t p.
Clinical outcomes within treatment
Percentage of days abstinent during treatment (Mean ± SD) 9.12/3.37 2.7 .007 - - - - - ns 8.7/4.4 2 0.48 - - ns 8.5/3.29 2.58 .01
Percentage cocaine-negative samples during treatment (Mean ± SD) - - ns - - - - - ns - - ns - - ns - - ns
Achieved 3 or more weeks of consecutive cocaine abstinence (N (%)) .62/.27 1.86 .025 - - - .65/.28 1.92 .021 - - ns - - ns - - ns
Longest duration abstinence during treatment (days) (Mean ± SD) 9.94/2.81 3.54 .001 - - - 7.63/2.91 2.62 .009 - - ns - - ns - - ns
Retained and abstinence in last week of treatment (N (%)) - - ns - - - - - ns - - ns - - ns - - ns
Complete abstinence during treatment (N (%)) - - ns - - - - - ns - - ns - - ns - - ns
Clinical outcomes at follow-up
Percentage of days abstinent at follow-up month 1 (Mean ± SD) 7.51/3.36 2.23 .026 - - - - - ns - - ns - - ns - - ns
Employment at follow-up month 1 (N (%)) 3.74/.39 42.4 .001 3.89/.53 49.1 .001 - - ns 3.32/.46 27.6 .001 - - ns 4.32/.47 75.4 .001
Percentage of days abstinent at follow-up month 3 (Mean ± SD) - - ns - - ns - - ns - - - - - ns - - ns
Employment at follow-up month 3 (N (%)) 2.65/.31 14.2 .001 2.64/.42 14 .001 - - ns 2.15/.39 8.59 .001 - - ns 3.14/.35 23.1 .001
Percentage of days abstinent at follow-up month 6 (Mean ± SD) - - ns - - ns - - ns - - - - - ns - - ns
Employment at follow-up month 6 (N (%)) 1.91/31 6.77 .001 1.36/.38 3.89 .001 - - ns 1.38/.39 3.98 .001 - - ns 1.89/.3 6.63 .001

UU = unemployed at baseline and at the end-of-treatment; EU = employed at baseline and unemployed at the end-of-treatment; UE = unemployed at baseline and employed the end-of-treatment; EE = and employed at baseline and at the end-of-treatment; SE = Standard Error; OR = Odds Ratio.; ns = statistically non-significant.